Synthetic Biology: Treating Cancer with E. Coli - 1 of 2

J. Chris Anderson, professor of bioengineering at UC Berkeley, leads a discussion on synthetic biology. The discussion starts with a detailed overview of synthetic biology (and its distinction from genetic engineering). Chris then dives into the meat of his work, engineering E. Coli strains to target cancer cells. The discussion concludes with an extensive talk about ethical and social ramifications of this research, from biosecurity/bioterrorism to patent licensing issues.

Recorded at Down to a Science event on 2/16

For more info: http://www.sciencecafesf.com

Category:

Education

Tags:

• Down to a Science
• Science Cafe
• Synthetic Biology
• Chris Anderson
• BioSecurity
• Biosafety
• Ethics
• Cancer Treatment
• E Coli

[Jasoldier1]

Fantastic Work Chris, the phage infection methodology is really cool.

Thanks for taking the time to put this together kishorehari